Attention-deficit/hyperactivity disorder in adults: A survey of current practice in psychiatry and primary care

Archives of Internal Medicine

Volumn 164, Issue 11, 2004, Pages 1221-1226

  Faraone, Stephen V ^a,b,c,d   Spencer, Thomas J ^a,b   Montano, Brendan ^d   Biederman, Joseph ^a,b  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c Harvard Inst Psychiat E/G   (United States)

^d UNIVERSITY OF CONNECTICUT   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMFEBUTAMONE; AMPHETAMINE; ANTIDEPRESSANT AGENT; ATOMOXETINE; CITALOPRAM; DEXAMPHETAMINE; FLUOXETINE; GENERIC DRUG; METHYLPHENIDATE; NORADRENALIN UPTAKE INHIBITOR; PAROXETINE; PEMOLINE; PSYCHOSTIMULANT AGENT; SERTRALINE; TRICYCLIC ANTIDEPRESSANT AGENT; VENLAFAXINE;

ADULT; ATTENTION DEFICIT DISORDER; CONTROLLED RELEASE FORMULATION; DEPRESSION; DRUG EFFICACY; HUMAN; HYPERACTIVITY; MAJOR CLINICAL STUDY; MENTAL DISEASE; ONSET AGE; PATIENT REFERRAL; PRESCRIPTION; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; PSYCHIATRIC DIAGNOSIS; PSYCHOPHARMACOTHERAPY; REVIEW; SYMPTOMATOLOGY; ARTICLE; CLINICAL PRACTICE; PRIMARY HEALTH CARE; PSYCHIATRY;

ADULT; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; HUMANS; PHYSICIAN'S PRACTICE PATTERNS; PRIMARY HEALTH CARE; PSYCHIATRY; REFERRAL AND CONSULTATION;

EID: 3042693000     PISSN: 00039926     EISSN: None     Source Type: Journal    
DOI: 10.1001/archinte.164.11.1221     Document Type: Review

References (33)

1. Barkley R. Age dependent decline in ADHD: true recovery or statistical illusion? ADHD Rep. 1997;5:1-5.
2. Downey K, Stelson F, Pomerleau O, Giordiani, B. Adult attention deficit hyperactivity disorder: psychological test profiles in a clinical population. J Nerv Ment Dis. 1997;185:32-38.
3. Murphy P, Schachar R. Use of self-ratings in the assessment of symptoms of attention deficit hyperactivity disorder in adults. Am J Psychiatry. 2000;157:1156-1159.
4. Faraone SV. Attention deficit hyperactivity disorder in adults: implications for theories of diagnosis. Curr Dir Psychol Sci. 2000;9:33-36.
5. Murphy K, Barkley R. Prevalence of DSM-IV symptoms of ADHD in adult licensed drivers: implications for clinical diagnosis. J Atten Disord. 1996;1:147-161.
6. Heiligenstein E, Conyers LM, Berns AR, Miller MA, Smith MA. Preliminary normative data on DSM-IV attention deficit hyperactivity disorder in college students. J Am Coll Health. 1998;46:185-188.
7. US Census Bureau Web site. DP-1: Profile of General Demographic Characteristics: 2000. Data set: Census 2000 Summary File 1 (SF 1). Available at: http://factfinder census.gov/servlet/BasicFactsTable?_lang=en&_vt_name= DEC_2000_SF1_U_DP1&geo_id=01000US. Accessed November 21, 2003.
8. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition. Washington, DC: American Psychiatric Association; 1994.
9. Biederman J, Faraone SV, Milberger S, et al. Predictors of persistence and remission of ADHD: results from a four-year prospective follow-up study of ADHD children. J Am Acad Child Adolesc Psychiatry. 1996;35:343-351.
10. Biederman J, Faraone SV, Spencer T, Wilens T, Mick E, Lapey KA. Gender differences in a sample of adults with attention deficit hyperactivity disorder. Psychiatry Res. 1994;53:13-29.
11. Biederman J, Faraone SV, Spencer T, et al. Patterns of psychiatric comorbidity, cognition, and psychosocial functioning in adults with attention deficit hyperactivity disorder. Am J Psychiatry. 1993;150:1792-1798.
12. Seidman LJ, Biederman J, Weber W, Hatch M, Faraone SV. Neuropsychological function in adults with attention-deficit hyperactivity disorder. Biol Psychiatry. 1998;44:260-268.
13. Barkley R, Murphy K, Kwasnik D. Psychological adjustment and adaptive impairments in young adults with ADHD. J Atten Disord. 1996;1:41-54.
14. Barkley R, Murphy K, Kwasnik D. Motor vehicle driving competencies and risks in teens and young adults with attention deficit hyperactivity disorder. Pediatrics. 1996;98:1089-1095.
15. Faraone SV, Biederman J, Feighner JA, Monuteaux MC. Assessing symptoms of attention deficit hyperactivity disorder in children and adults: which is more valid? J Consult Clin Psychol. 2000;68:830-842.
16. Faraone SV, Biederman J, Weiffenbach B, et al. Dopamine D4 gene 7-repeat allele and attention deficit hyperactivity disorder. Am J Psychiatry, 1999;156:768-770.
17. Zametkin AJ, Nordahl TE, Gross M, et al. Cerebral glucose metabolism in adults with hyperactivity of childhood onset. N Engl J Med. 1990;323:1361-1366.
18. Alpert JE, Maddocks A, Nierenberg AA, et al. Attention deficit hyperactivity disorder in childhood among adults with major depression. Psychiatry Res. 1996;62:213-219.
19. Spencer T, Wilens T, Biederman J, Faraone SV, Ablon JS, Lapey K. A double-blind, crossover comparison of methylphenidate and placebo in adults with childhood-onset attention-deficit hyperactivity disorder. Arch Gen Psychiatry. 1995;52:434-443.
20. Spencer T, Biederman J, Wilens T, et al. Efficacy of a mixed amphetamine salts compound in adults with attention-deficit/hyperactivity disorder. Arch Gen Psychiatry. 2001;58:775-782.
21. Michelson D, Faries D, Wernicke J, et al. Atomoxetine in the treatment of children and adolescents with attention-deficit/hyperactivity disorder: a randomized, placebo-controlled dose-response study, Pediatrics. 2001;108:E83.
22. Michelson D, Allen AJ, Busner J, et al. Once-daily atomoxetine treatment for children and adolescents with attention deficit hyperactivity disorder: a randomized placebo-controlled study. Am J Psychiatry. 2002;159:1896-1901.
23. Michelson D, Adler L, Spencer T, et al. Atomoxetine in adults with ADHD: two randomized, placebo-controlled studies. Biol Psychiatry. 2003;53:112-120.
24. Wolraich M, Greenhill LL, Pelham W, et al. Randomized, controlled trial of OROS methylphenidate once a day in children with attention deficit/hyperactivity disorder. Pediatrics. 2001;108:883-892.
25. Biederman J, Lopez FA, Boellner SW, Chandler MC. A randomized, double-blind, placebo-controlled, parallel-group study of SLI381 in children with attention-deficit/hyperactivity disorder. Pediatrics. 2002;110:258-266.
26. Wilens TE, Biederman JB, Mick E, Spencer T. A systematic assessment of tricyclic antidepressants in the treatment of adult attention-deficit hyperactivity disorder. J Nerv Ment Dis. 1995;183:48-50.
27. Wilens TE, Biederman J, Prince J, et al. Six-week, double-blind, placebo-controlled study of desipramine for adult attention deficit hyperactivity disorder. Am J Psychiatry. 1996;153:1147-1153.
28. Spencer T, Biederman J, Heiligenstein J, et al. An open-label, dose-ranging study of atomoxetine in children with attention deficit hyperactivity disorder. J Child Adolesc Psychopharmacol. 2001;11:251-265.
29. Kratochvil CJ, Bohac D, Harrington M, Baker N, May D, Burke WJ. An open-label trial of tomoxetine in pediatric attention deficit hyperactivity disorder. J Child Adolesc Psychopharmacol. 2001;11:167-170.
30. Kratochvil CJ, Heiligenstein J, Dittmann R, et al. Atomoxetine and methylphenidate treatment in children with ADHD: a prospective randomized, open-label trial. J Am Acad Child Adolesc Psychiatry. 2002;41:776-784.
31. Spencer T, Biederman J, Wilens T, et al. Effectiveness and tolerability of tomoxetine in adults with attention deficit hyperactivity disorder. Am J Psychiatry. 1998;155:693-695.
32. Faraone SV, Biederman J, Spencer T, et al. Attention-deficit/ hyperactivity disorder in adults: an overview. Biol Psychiatry. 2000;48:9-20.
33. Biederman J, Mick E, Faraone SV. Age-dependent decline of symptoms of attention deficit hyperactivity disorder: impact of remission definition and symptom type. Am J Psychiatry. 2000;157:816-818.